Survival tail is not a trial endpoint. No P-value, post hoc data dredged rGBM. Not part of the original protocol, at best an exploratory data point, but certainly not for regulatory approval.
If you understood how the FDA operates -- it is regulations (law) or guidelines (FDA exercising their rule making power). No "rules."
Market Data 
Markets 
AI
